Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2020

Planlagt Fastgjort Låst Flyttet Genmab
943 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #506

    any conclusions was "premature and scientifically unsound".

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #507

      Even if the drug proves successful, it is still experimental, and only limited quantities of such drugs are usually available. Gilead has increased production to meet demand for use in trials. On April 5th, it said it had enough to supply more than 140,000 patients.

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #508

        These sorts of numbers are larger than would be required by clinical trials, so suggest that Gilead is ramping up production for clinical use. The firm also said it was hoping to increase output again as raw materials became available. Looking further ahead, at even broader use, the firm has set an “ambitious goal” of producing more than 500,000 treatment courses by October, and 1m by the end of the year, from a geographically diverse group of suppliers.

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #509

          Just a moment...

          favicon

          (www.economist.com)

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #510

            Genmab tilbage i kanalen https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/83827_April_18_genmab.JPG

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #511

              Dara i leukemi https://twitter.com/michaelodwyermd/status/1251513471080022019?s=21

              1 Reply Last reply
              0
              • G Offline
                G Offline
                GeorgeBest
                wrote on sidst redigeret af
                #512

                Link til Twitter, virker hos mig.

                1 Reply Last reply
                0
                • T Offline
                  T Offline
                  transalp
                  wrote on sidst redigeret af
                  #513

                  Go morgen.. 🙂

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    GeorgeBest
                    wrote on sidst redigeret af
                    #514

                    Amyloidosis: Safety Run-in trial of Phase 3 Dara-CYBORDE trial showed 82% >VGPR with high renal organ response rate https://twitter.com/slentzsch/status/1251703290598916099?s=21

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #515

                      https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30143-9/fulltext
                      Evolving role of Daratumumab: From backbencher to a frontline agent https://sci-hub.tw/https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30143-9/fulltext

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #516

                        https://sci-hub.tw/https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30143-9/fulltext

                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          transalp
                          wrote on sidst redigeret af
                          #517

                          Go morgen frostklar flot
                          morgen .. 🙂

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #518

                            US FDA and EMA accept applications for Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time https://www.finanzen.ch/nachrichten/aktien/us-fda-and-ema-accept-applications-for-roches-ocrevus-ocrelizumab-shorter-2-hour-infusion-time-1029105760

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #519

                              Ja, snart tid til st få Ofa på banen.

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #520

                                Roche kører sideløbende med udvikling af Ocrevus til sc version med HALOs ENHANZE teknologi.

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #521

                                  Der bliver kamp til stregen og Novartis skal stå tidligt op for at presse Roche af banen.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #522

                                    Novartis starting a new "An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab (ARTIOS)" https://www.clinicaltrials.gov/ct2/show/NCT04353492?cond=Multiple+Sclerosis&sfpd_s=04%2F06%2F2020&sfpd_d=14&sel_rss=new14

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #523

                                      Aggressiv approach EL 🙂

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #524

                                        because they say 'transitioning from...' instead of 'relapsing from....' , right? actively looking to switch patients into ofa strategy it seems

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #525

                                          Yes if the patients cant se the benefit. We show them. Good to se from a investor view.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger